Sulatha is the Founder & CEO of Kaya17, Inc. and co-inventor of the Kaya17 platform technology, leading to development of a Point of Care, Rapid testing solution for COVID-19. As a serial entrepreneur, Dwarakanath has more than 25 years of experience in taking several products from bench to market under regulatory environment.
While working for various reputed companies such as Bayer Diagnostics (Siemens Heatheniers) and Thermo Fisher Scientific, she brought in various innovations that lead shorter time to market for critical diagnostics products. As a part Medical and Scientific Affairs, Assistant Director at Roche Molecular Systems, managed the Infectious Diseases group focused on HIV and Hepatitis.
Formerly, as the founder/CSO of Nano Science Diagnostics, Dwarakanath was instrumental in developing tests for bacteria in food and Point of Care tests for Strep and Staph with innovations in nanotechnology. She was the director of AC2 Bioscience Incubator in Austin TX, where she conceptualized the life science incubator, that currently hosts 12 companies and raised $10M from various government sources. As a part of National Science Foundation InnovATE BIO center, she co-chairs the National Industry and Workforce Advisory Council.